NouBio Inc, founded with a mission to revolutionize the cultivated meat industry, focuses on providing sustainable and animal-free technology solutions. The company's vision is to unlock a future where a significant portion of products are made through cell-based biomanufacturing, contributing to a trillion-dollar bioeconomy. NouBio's core offerings include market-ready products that reduce production costs by 95%, while maintaining high performance and scalability. Their technology also extends to other sectors like vaccine development, human tissue biomanufacturing, regenerative medicine, and longevity cellular therapies.

NouBio has attracted notable investors and industry leaders who support its innovative approach to biomanufacturing. The company has achieved significant milestones, including substantial cost reductions in cultivated meat production, which positions it as a key player in the bio-intelligent manufacturing space. NouBio's impact is evident in its potential to transform multiple sectors by making cell-based products more accessible and affordable, thereby advancing the broader adoption of sustainable biomanufacturing practices.